Capula Management’s Verve Therapeutics VERV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-48,467
Closed -$644K 507
2024
Q1
$644K Buy
48,467
+3,009
+7% +$40K 0.02% 128
2023
Q4
$634K Buy
+45,458
New +$634K 0.03% 90